Krsnaa Diagnostics Ltd

₹ 476 -0.26%
07 Dec - close price
About

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]

Key Points

Fastest growing Diagnostic center[1] Krsnaa is one of the fastest-growing diagnostic service providers in the country. Total Centre count increased at a CAGR of 39% from 682 in FY18 to 1,803 in FY21. The company has an extensive network of integrated diagnostic centers across India primarily in non-metro and lower-tier cities and towns. As of June 30, 2021, the company-operated 1,823 diagnostic centers offering radiology and pathology services in 13 states across India.

  • Market Cap 1,495 Cr.
  • Current Price 476
  • High / Low 800 / 446
  • Stock P/E 21.0
  • Book Value 227
  • Dividend Yield 0.52 %
  • ROCE 18.2 %
  • ROE 15.4 %
  • Face Value 5.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 103% CAGR over last 5 years
  • Debtor days have improved from 67.9 to 47.6 days.

Cons

  • Promoter holding is low: 27.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
150 98 96 132 108 106 108 112 121
107 79 63 91 76 75 78 81 87
Operating Profit 43 19 33 42 32 31 30 31 34
OPM % 28% 19% 35% 31% 29% 29% 28% 28% 28%
4 3 3 3 3 4 4 5 4
Interest 6 6 7 6 8 2 2 1 2
Depreciation 9 10 10 10 10 11 10 12 13
Profit before tax 31 6 20 29 17 22 22 22 24
Tax % 26% 29% 155% 25% 25% 23% 12% 24% 24%
Net Profit 23 4 -11 22 13 17 19 17 18
EPS in Rs 43.81 7.73 -16.94 16.64 3.99 5.49 6.16 5.35 5.72
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
36 57 147 258 396 455 447
35 42 87 373 302 320 320
Operating Profit 0 15 60 -114 94 135 126
OPM % 1% 26% 41% -44% 24% 30% 28%
3 4 2 13 265 15 17
Interest 6 6 16 25 26 18 7
Depreciation 5 10 26 32 37 41 46
Profit before tax -7 2 21 -158 295 90 90
Tax % -6% 8% 40% 29% 37% 21%
Net Profit -8 2 12 -112 185 71 71
EPS in Rs -15.05 4.01 24.15 -216.83 284.73 22.52 22.72
Dividend Payout % -0% -0% -0% -0% -0% 11%
Compounded Sales Growth
10 Years: %
5 Years: 52%
3 Years: 46%
TTM: 3%
Compounded Profit Growth
10 Years: %
5 Years: 103%
3 Years: 78%
TTM: 163%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -35%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
55 70 146 20 249 16 16
Reserves 4 6 43 -217 -17 671 698
81 37 189 231 232 41 63
74 128 256 611 388 149 153
Total Liabilities 163 176 493 630 609 877 929
59 116 223 275 309 386 393
CWIP 20 6 42 9 4 28 44
Investments 0 0 0 0 0 0 0
85 53 228 345 297 463 491
Total Assets 163 176 493 630 609 877 929

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2019 Mar 2020 Mar 2021 Mar 2022
59 61 38 119 129
-53 -201 -77 -67 -241
-37 145 6 20 176
Net Cash Flow -31 4 -33 71 64

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016 Mar 2017 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 87 91 140 87 69 48
Inventory Days 21 24 89
Days Payable 76 99 878
Cash Conversion Cycle 32 15 -650 87 69 48
Working Capital Days 57 -43 -100 -3 -23 -36
ROCE % 7% -65% 129% 18%

Shareholding Pattern

Numbers in percentages

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
27.38 27.38 27.38 27.38 27.79
6.00 4.44 4.49 4.27 4.06
30.16 30.14 28.64 27.36 20.43
36.45 38.04 39.49 40.98 47.71

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents